The NIH and the Alzheimer’s Association is sponsoring an important study that will shape the way we understand, and eventually treat, people who develop symptoms of Alzheimer’s disease between 40 and 64 years of age. Currently, PCA syndrome is underrepresented. I urge you to consider contacting the study group to see if you can participate. Read more about it here:

Study Team and how to contact them:
Telephone: 317-963-7436

Eligibility for inclusion is listed below. It is okay if you do not understand these terms because the study team will walk you through eligibility.

Read more about it here:

Inclusion Criteria

  1. 1. Meets NIA-AA criteria for mild cognitive impairment due to Alzheimer’s disease (AD) or probable AD dementia
  2. 2. Have a global CDR score ≤ 1.0
  3. 3. Have capacity to provide informed consent (IC) or has a legal authorized representative or guardian who provides IC
  4. 4. Age between 40-64 years (inclusive) at the time of consent
  5. 5. Must have a study partner (informant) who spends a minimum average of at least 10 hours per week with the participant (e.g., family member, significant other, friend, caregiver) who is generally aware of the participants’ daily activities and can provide information about the participant’s cognitive and functional performance. If the participant does not have a study partner who spends 10 face-to-face hours per week, other arrangements for identifying a viable study partner will be granted on a case-by-case basis by the Site PI
  6. 6. Willing and able to complete longitudinal study procedures aside from LP which is an optional procedure
  7. 7. Not pregnant or lactating. Women must be two years post-menopausal, be surgically sterile, or have a negative pregnancy test prior to each PET scan
  8. 8. Fluent in English

LEADS – Longitudinal Early-Onset Alzheimer’s Disease Study

When it Comes to Ending Alzheimer’s Disease, Time is of the Essence

Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS)

NIH – National Institute on Aging

–For more information on the LEADS Study, go to “PCA Support Group Lectures & Webinars” to view the video of the Webinar Lecture (10/21/2020) given by both Drs. Victoria S. Pelak & Liana G. Apostolova (scroll to the end of the video for more information on LEADS).

Clinical Trials Information Posted by Dr. Victoria Pelak:

Many patients ask whether there are research studies that they could be involved in since there is no treatment available for PCA. Since studies are constantly changing, the best way to find the answer to that question is to start with web pages that allow for the use of a searchable database for any study related to Posterior Cortical Atrophy, or any other disorder, and this can be found at the following address: This website allows researchers from around the world to register a clinical research study (or clinical trial) and provides an important resource to patients, families, healthcare providers, researchers, and the general public. More information about the background for this website can be found at

The site is maintained by the National Library of Medicine at the National Institutes of Health, or NIH, in Bethesda, Maryland. The NIH is a federally-funded US institution that conducts both human medical research and basic laboratory research at its large facility in Bethesda, MD, and the NIH funds research all over the United States with an annual budget of approximately $32 billion dollars. Please be aware that the studies in the database should not be considered “NIH studies”. Thus, if a research study is listed in this database, it does not mean that the research study is supported or reviewed by the NIH. Instead, study information is submitted or registered by those who conduct the study regardless of where the funding is coming from to run the study and regardless of the degree of oversight. The NIH does not review the studies for merit, ethics, or other issues of importance to family members and patients who are interested in participating in the study.

Each study provides information about who is sponsoring the study with funding, and some funding sponsors, such as the NIH, require the research they fund to be listed. Within the information listed for each study will be who is supporting the study with money to conduct it. In some cases it will be the NIH. In other cases it will be private foundations, or pharmaceutical companies, or other governments such as China. Some studies will be for observational purposes only with no research therapeutic (or treatment) intervention. These observational studies have various goals but most have a goal to gather more information about the disorder.

Other studies listed will be research therapeutic trials that include treatments to improve the disease or disease symptoms or to study whether the treatment is safe. At the database search site, a term can be entered to search the database. We recommend starting with the term “Posterior Cortical Atrophy” to begin a search looking for studies with relevance to Posterior Cortical Atrophy.

Thank you for Your Donations

Linda S. Munilla
John & Joanne Hare
Lauren Munilla
Guin & Ronald Lyster
Janella Rosenthal
Lucy & Anthony Turrisi
An Award-Winning New Mexican Filmmaker
Carol Hawkins
Kurt & Melissa Ronacher
Jessica Fish
Kimberly Best
Jaime & Rose Pabon
Roberta Schain
Michelle Lutz
Dorothy & Dwight Finkel
Jill & Theodore Nelson
Susan Bardwell & Frank Scalise
Dudley A. Eppel, Jr.
Michelle Doe
Andy Weinheimer & Sue Eyler
Robert Yetz
Colleen Peace
Michael & Martha Montano
Barbara & Lee Mendel

Kenneth Tiffany
Edwin Baxter
Thomas & Joy White

Susan & John Quinlan
Victoria Pelak, MD

The Brain and Vision Fund wishes to thank our generous donors! The funds have helped support a student researcher and research presentations on Posterior Cortical Atrophy at National and International Conferences. Donations also made it possible to hire two summer interns beginning June 10, 2019, Stephanie Serva & Vishal Krishnan. Thank you for making a difference for people with PCA.

PCA Summer Interns – Stephanie Serva & Vishal Krishnan

Summer PCA Research Interns Presentations

CBS News Interview

October 24, 2018: Rare Form of Alzheimer’s Affects What The Eyes See – CBS News Interview of Dr. Pelak & Robert Yetz: Click Here

©2018 Colorado PCA Support (PCA). All rights reserved

User Login